Podcasts about american thyroid association ata

În cadrul ediției de pe 8 noiembrie 2022 a emisiunii #știința360 de pe Radio România Cultural, Dr. Marius Geantă, Președintele Centrului pentru Inovație în Medicină #inomed, a comentat avansurile științifice ale momentului. Pacienţii spitalizaţi pentru COVID-19, forma severă, şi care nu au istoric de afectare tiroidiană, pot să dezvolte tiroidită asociată infecţiei cu SARS-CoV-2, care persistă până la un an. Acestea sunt rezultatele unui studiu prezentat în cadrul întâlnirii anuale a American Thyroid Association (ATA) 2022. Studiul şi-a propus supravegherea funcţiei tiroidiene post COVID-19 pe termen lung, aceste consecinţe ale infecţiei SARS-CoV-2 fiind puţin investigate. Studiul a inclus 183 de pacienţi spitalizaţi cu forme severe de COVID-19 în Italia. La momentul includerii în studiu, 10% dintre aceştia au avut tireotoxicoză, iar la 2-3 luni post-infecţie, 28% au avut arii de tiroidită evidenţiate la ecografie. Disfuncția tiroidiană a fost tranzitorie, iar leziunile de tiroidită s-au micşorat progresiv în timp. Aceşti pacienţi cu modificări la ecografie au avut o probabilitate mai crescută de a avea concentraţii serice ridicate de FT4 şi interleukină 26, 60% dintre ei au avut un nivel scăzut al TSH-ului, iar 25% au avut valori normale ale TSH-ului. Evaluarea prezenţei autoanticorpilor a indicat absenţa dezvoltării anticorpilor antitireoglobulină, a celor împotriva tiroid peroxidazei, precum şi a celor anti-receptor de TSH. La nivel tiroidian, s-au evidenţiat celule T cu memorie, care nu au fost detectate şi în sânge. Limfocitele T specifice împotriva SARS-CoV-2 au fost depistate în număr mai mare la nivel tiroidian, faţă de sânge. Studiul nu a putut clarifica dacă existenţa acestor arii de inflamaţie tiroidiană va avea consecinţe pe termen lung. De asemenea, nu a putut explica de ce unii pacienţi dezvoltă tiroidită atipică şi alţii nu. Mai multe detalii despre subiectele dezbătute în această săptămână: https://raportuldegarda.ro/stiri-covid-romania/ https://raportuldegarda.ro/esential-covid-19-inflamatie-tiroidiana-post-infectie/

In Episode 149 I sit down with Endocrinologist Dr Brittany Henderson to talk about thyroid health. Whether you have a thyroid condition yourself, or are just interested in learning more about how this organ affects your health, I'm sure you will enjoy this episode. Specifically we cover: What the field of Endocrinology is focussed on What makes an organ an endocrine organ Type of endocrine related disorders What our thyroid is and why it's important to our health Common thyroid disorders (e.g Hashimotos) Blood tests to monitor thyroid health (e.g antibody tests) Managing thyroid conditions with a particular focus on foods and nutrients (e.g iodine and selenium) and much more Brittany Henderson, MD: Brittany Henderson, MD, ECNU is board-certified in internal medicine and endocrinology, with advanced training in thyroid disorders, including Hashimoto's thyroiditis, Graves Disease, thyroid nodules, and thyroid cancer. Originally from Cleveland, Ohio, she graduated near the top of her class at Northeastern Ohio Medical University, where she received the honor of Alpha Omega Alpha (AOA). She completed her endocrinology fellowship training under a National Institutes of Health (NIH) research-training grant at Duke University Medical Center. She then served as Medical Director for the Thyroid and Endocrine Tumor Board at Duke University Medical Center and as Clinical Director for the Thyroid and Endocrine Neoplasia Clinic at Wake Forest University Baptist Medical Center. She is also one of the founders and the current Co-President of the American College of Thyroidology. She has received multiple prestigious grants from the American Thyroid Association (ATA) and ThyCa (Thyroid Cancer Survivors' Association, Inc.). Her work has been featured on the cover of Thyroid and in many other scientific journals including Endocrinology, Gut, and Oncotarget. She desires to improve quality of life for those living with thyroid disease both through novel research and medical guidance. For patients living with Hashimoto's disease, she believes that knowledge is power. Her clinical practice is dedicated to patients with thyroid disease. She specializes in autoimmune thyroid disease, thyroid nodules, thyroid cancer, ethanol ablation, and advanced minimally invasive techniques. In addition to using a mainstream medical approach, Dr. Henderson also uses complementary medicine to explore underlying root causes of thyroid disease. Resources: Connect with Brittany on Instagram Brittany's book Charleston Thyroid Center Want to support the show? If you are enjoying the Plant Proof podcast a great way to support the show is by leaving a review on the Apple podcast app. It only takes a few minutes and helps more people find the episodes. Simon Hill, Nutritionist, Sports Physiotherapist Creator of Plantproof.com and host of the Plant Proof Podcast Author of The Proof is in the Plants Connect with me on Instagram and Twitter Download my two week meal plan

In Episode 149 I sit down with Endocrinologist Dr Brittany Henderson to talk about thyroid health. Whether you have a thyroid condition yourself, or are just interested in learning more about how this organ affects your health, I'm sure you will enjoy this episode.Specifically we cover:What the field of Endocrinology is focussed onWhat makes an organ an endocrine organType of endocrine related disordersWhat our thyroid is and why it's important to our healthCommon thyroid disorders (e.g Hashimotos)Blood tests to monitor thyroid health (e.g antibody tests)Managing thyroid conditions with a particular focus on foods and nutrients (e.g iodine and selenium)and much moreBrittany Henderson, MD:Brittany Henderson, MD, ECNU is board-certified in internal medicine and endocrinology, with advanced training in thyroid disorders, including Hashimoto's thyroiditis, Graves Disease, thyroid nodules, and thyroid cancer. Originally from Cleveland, Ohio, she graduated near the top of her class at Northeastern Ohio Medical University, where she received the honor of Alpha Omega Alpha (AOA). She completed her endocrinology fellowship training under a National Institutes of Health (NIH) research-training grant at Duke University Medical Center. She then served as Medical Director for the Thyroid and Endocrine Tumor Board at Duke University Medical Center and as Clinical Director for the Thyroid and Endocrine Neoplasia Clinic at Wake Forest University Baptist Medical Center. She is also one of the founders and the current Co-President of the American College of Thyroidology.She has received multiple prestigious grants from the American Thyroid Association (ATA) and ThyCa (Thyroid Cancer Survivors' Association, Inc.). Her work has been featured on the cover of Thyroid and in many other scientific journals including Endocrinology, Gut, and Oncotarget. She desires to improve quality of life for those living with thyroid disease both through novel research and medical guidance. For patients living with Hashimoto's disease, she believes that knowledge is power.Her clinical practice is dedicated to patients with thyroid disease. She specializes in autoimmune thyroid disease, thyroid nodules, thyroid cancer, ethanol ablation, and advanced minimally invasive techniques. In addition to using a mainstream medical approach, Dr. Henderson also uses complementary medicine to explore underlying root causes of thyroid disease.Resources:Connect with Brittany on InstagramBrittany's book Charleston Thyroid CenterWant to support the show?If you are enjoying the Plant Proof podcast a great way to support the show is by leaving a review on the Apple podcast app. It only takes a few minutes and helps more people find the episodes.Simon Hill, Nutritionist, Sports PhysiotherapistCreator of Plantproof.com and host of the Plant Proof PodcastAuthor of The Proof is in the PlantsConnect with me on Instagram and TwitterDownload my two week meal plan

Top Four Foods to Heal Your Thyroid Thyroid diseases can often lead to debilitating effects and symptoms. From mental fogginess and hair loss to rapid weight gain or weight loss, thyroid diseases can severely affect our lives. This is because the thyroid gland controls and influences body weight and our body's metabolic rate. More often than not, thyroid diseases can be caused by mere neglect, and/or certain factors. According to the American Thyroid Association (ATA), at least 20 million Americans suffer from a certain type of thyroid disease. They continue to state that over 60% of the 20 million Americans are unaware that they are suffering from the disease. Those that remain unaware of their condition are more likely to develop osteoporosis, cardiovascular diseases, thyroid cancer as well as other types of cancers. Hence, it is imperative that individuals get tested for thyroid disease as a precautionary measure. For those aware of their status, taking preventive measures like lifestyle changes and in extreme cases medications. One major factor in treating thyroid disease is often left out: food and nutrition. There are certain foods that contain high amounts of nutrients that have the ability to treat the thyroid.

During this interview, Dr. Tuttle discusses the following points: Challenges of managing thyroid cancer as outlined by the guidelines Scaling back care for insurance-challenged patients, and adopting a plan that gets the same result without needing the expensive tests Desired outcome is survival and no recurrence, a third is for no harm that would be caused by an unnecessary surgery Unwanted side affects of thyroid cancer include nerve damage, parathyroid damage, and infections RAI sometimes has unwanted side affects With technology, ultrasounds and biopsies, we know some cancers do not need to be treated, as they are now being found very early Change in ATA guidelines, low risk cancers can be considered for observation Two different kinds of patient profiles: Minimalist and Maximalist 1cm or 1.5cm? Patient characteristic, ultra sound characteristics, and the medical team characteristics weighs who is the most appropriate for observation 400 active surveillance patients currently at MSKCC Certain parts of the world are harder to offer observation as a treatment due to practicality, examples include Latina America where multi-nodular goiters are common, and Germany still is iodine deficient About Dr. Tuttle, in his words: I am a board-certified endocrinologist who specializes in caring for patients with advanced thyroid cancer. I work as part of a multidisciplinary team including surgeons, pathologists, radiologists, nuclear medicine specialists, and radiation oncologists that provides individualized care to patients treated at Memorial Sloan Kettering for thyroid cancer. In addition to treating patients I am also actively researching new treatments for advanced thyroid cancer. I am a professor of medicine at the Joan and Sanford I. Weill Medical College of Cornell University and travel extensively both in the US and abroad, lecturing on the difficult issues that sometimes arise in the management of patients with thyroid cancer. My research projects in radiation-induced thyroid cancer have taken me from Kwajalein Atoll in the Marshall Islands to the Hanford Nuclear power-plant in Washington State to regions in Russia that were exposed to fallout from the Chernobyl accident. I am an active member of the American Thyroid Association (ATA) and the Endocrine Society. In addition to serving on the ATA committee that produced the current guidelines for the management of benign and malignant nodules, I am also a Chairman of the National Comprehensive Cancer Network Thyroid Cancer Panel, a consultant to the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA, and a consultant to the Chernobyl Tissue Bank. NOTES Listen to Doctor Thyroid American Thyroid Association Dr. Michael Tuttle RELATED EPISODES 35: Rethinking Thyroid Cancer – When Saying No to Surgery Maybe Best for You with Dr. Allen Ho from Cedars-Sinai in Los Angeles 22: Avoiding Thyroid Cancer Surgery, Depending on the Size with Dr. Miyauchi from Kuma Hospital in Kobe, Japan 21: Diagnosed with Thyroid Cancer and You Say No to Surgery with Dr. Louise Davies

Many centers from around the world want to know how Memorial Memorial Sloan Kettering Cancer Center treats thyroid cancer.  A key member of the MSKCC is Dr. Michael Tuttle.  During this interview, Dr. Tuttle discusses the following points: Challenges of managing thyroid cancer as outlined by the guidelines Scaling back care for insurance-challenged patients, and adopting a plan that gets the same result without needing the expensive tests Desired outcome is survival and no recurrence, a third is for no harm that would be caused by an unnecessary surgery Unwanted side affects of thyroid cancer include nerve damage, parathyroid damage, and infections RAI sometimes has unwanted side affects With technology, ultrasounds and biopsies, we know some cancers do not need to be treated, as they are now being found very early Change in ATA guidelines, low risk cancers can be considered for observation Two different kinds of patient profiles: Minimalist and Maximalist 1cm or 1.5cm? Patient characteristic, ultra sound characteristics, and the medical team characteristics weighs who is the most appropriate for observation 400 active surveillance patients currently at MSKCC Certain parts of the world are harder to offer observation as a treatment due to practicality, examples include Latina America where multi-nodular goiters are common, and Germany still is iodine deficient About Dr. Tuttle, in his words: I am a board-certified endocrinologist who specializes in caring for patients with advanced thyroid cancer. I work as part of a multidisciplinary team including surgeons, pathologists, radiologists, nuclear medicine specialists, and radiation oncologists that provides individualized care to patients treated at Memorial Sloan Kettering for thyroid cancer. In addition to treating patients I am also actively researching new treatments for advanced thyroid cancer. I am a professor of medicine at the Joan and Sanford I. Weill Medical College of Cornell University and travel extensively both in the US and abroad, lecturing on the difficult issues that sometimes arise in the management of patients with thyroid cancer. My research projects in radiation-induced thyroid cancer have taken me from Kwajalein Atoll in the Marshall Islands to the Hanford Nuclear power-plant in Washington State to regions in Russia that were exposed to fallout from the Chernobyl accident. I am an active member of the American Thyroid Association (ATA) and the Endocrine Society. In addition to serving on the ATA committee that produced the current guidelines for the management of benign and malignant nodules, I am also a Chairman of the National Comprehensive Cancer Network Thyroid Cancer Panel, a consultant to the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA, and a consultant to the Chernobyl Tissue Bank. Clinical Expertise: Thyroid Cancer Languages Spoken: English Education: MD, University of Louisville School of Medicine Residencies: Dwight David Eisenhower Army Medical Center Fellowships: Madigan Army Medical Center Board Certifications: Endocrinology and Metabolism NOTES 22: Avoiding Thyroid Cancer Surgery, Depending on the Size with Dr. Miyauchi from Kuma Hospital in Kobe, Japan 21: Diagnosed with Thyroid Cancer and You Say No to Surgery with Dr. Louise Davies 35: Rethinking Thyroid Cancer – When Saying No to Surgery Maybe Best for You with Dr. Allen Ho from Cedars-Sinai in Los Angeles The American Thyroid Association

This podcast highlights original research published in the April 2017 issue of Otolaryngology–Head and Neck Surgery, the official journal of the American Academy of Otolaryngology—Head and Neck Surgery (AAO-HNS) Foundation. The objective for this study was to evaluate changes in distribution of reported thyroid nodule fine-needle aspiration (FNA) cytopathology results since implementation of the Bethesda classification and revised 2015 American Thyroid Association (ATA) guidelines for selecting nodules for biopsy. We observed a significantly increased proportion of indeterminate cytology and corresponding decrease in benign nodules compared with an earlier sample, predominately from an increase in AUS/FLUS. Multiple factors are likely involved, including selection of sonographically suspicious nodules for biopsy based upon 2015 ATA guidelines coupled with cytopathological interpretation by a new generation of cytopathologists trained in the era of Bethesda reporting; further study is required to make a definitive conclusion.   Click here to read the full article.